{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["182(1)"],"submitter":["Swaminathan L"],"pubmed_abstract":["<h4>Importance</h4>Peripherally inserted central catheters (PICCs) and midlines are frequently used for short-term venous access; whether one is safer than the other in this setting has not been adequately reported.<h4>Objective</h4>To compare outcomes between patients who had a PICC vs midline placed for the indication of difficult vascular access or antibiotic therapy for 30 or fewer days.<h4>Design, setting, and participants</h4>This cohort study analyzed data from a multihospital registry including patients admitted to a participating site from December 2017 through January 2020 who had a PICC or midline placement for the indications of difficult venous access or intravenous antibiotic therapy prescribed for 30 or fewer days. Data were analyzed from October 2020 to March 2021.<h4>Expos"],"journal":["JAMA internal medicine"],"pagination":["50-58"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8630646"],"repository":["biostudies-literature"],"pubmed_title":["Safety and Outcomes of Midline Catheters vs Peripherally Inserted Central Catheters for Patients With Short-term Indications: A Multicenter Study."],"pmcid":["PMC8630646"],"pubmed_authors":["Flanders S","O'Malley M","Horowitz J","Chopra V","Swaminathan L","Zhang Q"],"additional_accession":[]},"is_claimable":false,"name":"Safety and Outcomes of Midline Catheters vs Peripherally Inserted Central Catheters for Patients With Short-term Indications: A Multicenter Study.","description":"<h4>Importance</h4>Peripherally inserted central catheters (PICCs) and midlines are frequently used for short-term venous access; whether one is safer than the other in this setting has not been adequately reported.<h4>Objective</h4>To compare outcomes between patients who had a PICC vs midline placed for the indication of difficult vascular access or antibiotic therapy for 30 or fewer days.<h4>Design, setting, and participants</h4>This cohort study analyzed data from a multihospital registry including patients admitted to a participating site from December 2017 through January 2020 who had a PICC or midline placement for the indications of difficult venous access or intravenous antibiotic therapy prescribed for 30 or fewer days. Data were analyzed from October 2020 to March 2021.<h4>Expos","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jan","modification":"2025-04-21T16:07:56.464Z","creation":"2025-04-21T16:07:56.464Z"},"accession":"S-EPMC8630646","cross_references":{"pubmed":["34842905"],"doi":["10.1001/jamainternmed.2021.6844"]}}